Stephen Curtis

Stephen Curtis

Active Investor

Interim VP, Innovation & Impact Investing and Managing Director at BrightEdge - American Cancer Society

Canton, Massachusetts

Stephen Curtis, Interim VP, Innovation & Impact Investing and Managing Director at BrightEdge - American Cancer Society is an active investor based in Canton, Massachusetts. This profile covers what Stephen Curtis backs, at which stage, and how founders can reach out in 2026.

Investor type
VCPEInvestor
Stages
Early Stage VentureSeed
Invests in
Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseDeveloper Tools & DataIoT & Connected Devices
Location
Canton, Massachusetts
Typical check
$375K
Past investments
63

Notable investments

CoStim PharmaceuticalsInformedDNAMitobridgeVerastem OncologyCODA BiotherapeuticsTetherex PharmaceuticalsMotus TherapeuticsAstute MedicalClinical InkiPierianCullinan OncologyTriVascular

How to reach Stephen Curtis

Angels and operators like Stephen Curtis reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Stephen Curtis invest in?

Stephen Curtis invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Early Stage Venture and Seed. Match your sector and stage, then reach out with a personalized pitch.

How do I contact Stephen Curtis?

Unlock Stephen Curtis's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.

Similar investors

Browse all investorsIs this you? Email team@roundfunded.com to update or remove your profile.